- Main page
- Tests catalogue
- Anti-Striated Muscle Abs
Anti-Striated Muscle Abs
The anti-striated muscle antibody test is a specialized diagnostic tool used to assess patients for neuromuscular junction diseases, notably myasthenia gravis (MG). This test identifies autoantibodies targeting the contractile elements of striated muscle, including skeletal and cardiac muscle. It is particularly useful in diagnosing MG when acetylcholine receptor antibodies are absent. Utilizing immunofluorescence, the test detects these autoantibodies by applying a patient’s serum to primate tissue sections, visualized with fluorescent dyes. A positive result suggests a complex autoimmune response, often linked to thymoma in MG patients. While primarily associated with MG, these antibodies can also appear in conditions like Lambert-Eaton syndrome and certain cancers. The test requires a serum sample, with results typically available in 2-4 days. Clinically, the presence of these antibodies can influence treatment strategies and predict thymoma recurrence risk. Despite its utility, the test is not FDA-approved and is unavailable in New York state.
The anti-striated muscle antibody test is a specialized diagnostic tool used to assess patients for neuromuscular junction diseases, notably myasthenia gravis (MG). This test identifies autoantibodies targeting the contractile elements of striated muscle, including skeletal and cardiac muscle. It is particularly useful in diagnosing MG when acetylcholine receptor antibodies are absent. Utilizing immunofluorescence, the test detects these autoantibodies by applying a patient’s serum to primate tissue sections, visualized with fluorescent dyes. A positive result suggests a complex autoimmune response, often linked to thymoma in MG patients. While primarily associated with MG, these antibodies can also appear in conditions like Lambert-Eaton syndrome and certain cancers. The test requires a serum sample, with results typically available in 2-4 days. Clinically, the presence of these antibodies can influence treatment strategies and predict thymoma recurrence risk. Despite its utility, the test is not FDA-approved and is unavailable in New York state.
The lowest price from the last 30 days: £186
Awaiting result:
3 days
Collect material:
Blood
Prepare:
The anti-striated muscle antibody test is a vital diagnostic tool for assessing neuromuscular junction diseases, especially myasthenia gravis (MG). It detects autoantibodies targeting striated muscle elements, aiding in differential diagnosis when acetylcholine receptor antibodies are absent. Key points include:
- Methodology: Utilizes immunofluorescence to identify autoantibodies in serum samples.
- Interpretation: Positive results suggest MG, often linked to thymoma, and can indicate other conditions.
- Sample Requirements: Serum sample in SST, promptly processed and refrigerated.
- Clinical Significance: Guides treatment strategies, predicting MG risk and thymoma recurrence.
- Additional Tests: Negative results may necessitate further testing for comprehensive diagnosis.
The anti-striated muscle antibody test is essential for diagnosing neuromuscular junction diseases, especially myasthenia gravis (MG). It detects autoantibodies targeting striated muscle, aiding in differential diagnosis when acetylcholine receptor antibodies are absent. Key points include:
- Indications: Primarily for MG diagnosis, especially with thymoma.
- Methodology: Uses immunofluorescence to identify autoantibodies.
- Interpretation: Positive results suggest MG or other conditions like Lambert-Eaton syndrome.
- Sample Requirements: Serum sample, properly handled.
- Turnaround: Typically 2-4 days.
- Clinical Significance: Guides treatment strategies and predicts thymoma recurrence.
Understanding test results for the anti-striated muscle antibody test is crucial for diagnosing neuromuscular junction diseases, particularly myasthenia gravis (MG). Here's a brief overview:
- Positive Result: Indicates the presence of autoantibodies, suggesting MG or related conditions, especially in patients with thymoma.
- Negative Result: Helps rule out thymoma in MG patients, except in specific cases.
- Clinical Implications: Guides treatment strategies and predicts disease progression.
- Additional Testing: May be needed if results are negative to confirm MG diagnosis.
- Sample Handling: Proper collection and storage are essential for accurate results.
The lowest price from the last 30 days: £186
What is GetLabTest.com?
How do I get started with GetLabTest.com?
What diseases can GetLabTest.com detect?
How do I prepare for testing with GetLabTest.com?
Can I speak with a doctor about my results?
Is testing with GetLabTest.com covered by insurance?
How long does it take to receive the test results?
Can I access my test results online?
Is my personal information kept confidential?
What if I have questions or concerns about my test results?